GENEVA, Nov. 6 -- EXIR, INC. filed a patent application (US2026/026178) for “SYSTEMS AND METHODS FOR BIOLOGICAL SALVAGE OF TOXICITY LIMITED OR FAILED THERAPIES”. With publication no. WO/2026/232012, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C12N 5/079
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....